Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 7 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 6 days agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 7 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 6 days agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 7 days ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 4 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
US FDA puts partial clinical hold on BioNTech’s early-stage study of cancer drug
WHTC 1450 Holland· 7 days ago(Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug...
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 4 days agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 5 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 5 days agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Monday, Benzinga reports ...